Gordon Yip, MD | |
900 Kiely Blvd, Santa Clara, CA 95051-5329 | |
(408) 236-6400 | |
Not Available |
Full Name | Gordon Yip |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 24 Years |
Location | 900 Kiely Blvd, Santa Clara, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669546982 | NPI | - | NPPES |
00A842870 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | A84287 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kaiser Foundation Hospital-santa Clara | Santa clara, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Generex Biotechnology Corporation announced today that new immune response data from the on-going Phase II clinical trial of the AE37 breast cancer vaccine undertaken by Generex wholly-owned subsidiary Antigen Express, Inc. was presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) on June 2, 2012 in Chicago, IL.
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
Hybrid closed-loop insulin therapy improved glycemic control in adolescents and young adults with type 1 diabetes. These outcomes, derived from the International Diabetes Closed-Loop (iDCL) Trial, are reported in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT).
Australian doctors are prescribing antivirals for people with the flu who may not benefit, putting patients at risk of unnecessary side effects and potentially increasing the risk of antimicrobial resistance to these medications, researchers from the University of Adelaide have found.
› Verified 9 days ago
Entity Name | Permanente Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Generex Biotechnology Corporation announced today that new immune response data from the on-going Phase II clinical trial of the AE37 breast cancer vaccine undertaken by Generex wholly-owned subsidiary Antigen Express, Inc. was presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) on June 2, 2012 in Chicago, IL.
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
Hybrid closed-loop insulin therapy improved glycemic control in adolescents and young adults with type 1 diabetes. These outcomes, derived from the International Diabetes Closed-Loop (iDCL) Trial, are reported in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT).
Australian doctors are prescribing antivirals for people with the flu who may not benefit, putting patients at risk of unnecessary side effects and potentially increasing the risk of antimicrobial resistance to these medications, researchers from the University of Adelaide have found.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Gordon Yip, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3466 Ph: (510) 625-6262 | Gordon Yip, MD 900 Kiely Blvd, Santa Clara, CA 95051-5329 Ph: (408) 236-6400 |
News Archive
Generex Biotechnology Corporation announced today that new immune response data from the on-going Phase II clinical trial of the AE37 breast cancer vaccine undertaken by Generex wholly-owned subsidiary Antigen Express, Inc. was presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) on June 2, 2012 in Chicago, IL.
Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
Hybrid closed-loop insulin therapy improved glycemic control in adolescents and young adults with type 1 diabetes. These outcomes, derived from the International Diabetes Closed-Loop (iDCL) Trial, are reported in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT).
Australian doctors are prescribing antivirals for people with the flu who may not benefit, putting patients at risk of unnecessary side effects and potentially increasing the risk of antimicrobial resistance to these medications, researchers from the University of Adelaide have found.
› Verified 9 days ago
David Clarke, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 900 Kiely Blvd, Santa Clara, CA 95051 Phone: 408-236-6400 | |
Joseph S. Chou, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 900 Kiely Blvd, Santa Clara, CA 95051 Phone: 408-236-6400 | |
Farhana Ahmed, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 710 Lawrence Expy, Santa Clara, CA 95051 Phone: 408-851-7222 | |
Gurpreet K. Ahluwalia, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 900 Kiely Blvd, Santa Clara, CA 95051 Phone: 408-236-6400 | |
Smita V. Gavaskar, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 900 Kiely Blvd, Santa Clara, CA 95051 Phone: 408-236-6400 | |
Anna Park, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 Lawrence Expy, Hospital Medicine 3rd Floor, Santa Clara, CA 95051 Phone: 408-851-7679 | |
Farida T. Madraswala, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 900 Kiely Blvd, Santa Clara, CA 95051 Phone: 408-236-6400 |